ACE and congestive heart failure: Early identification of cardiac dysfunction is important, as further LVEF reductions or development of congestive heart failure may be prevented by cardio-protective treatment with beta-blockers and/or angiotensin converting enzyme (ACE) inhibitors, or by timely interruption of trastuzumab [1, 2].